Article
MMP-3 (5A/6A) polymorphism does not influence human smooth muscle cell invasion.
The Journal of surgical research - 15 Jun 2012
Maqbool Azhar, Keswani Anita, Galloway Stacey, O'Regan David J, Ball Stephen G, Turner Neil A, Porter Karen E
Abstract excerpt
BACKGROUND: Stromelysin (MMP-3) is an important regulator of vascular smooth muscle cell (SMC) invasion, a key contributor to saphenous vein (SV) bypass graft failure. The 5A allele of the common -1612 MMP-3 5A/6A promoter polymorphism reportedly confers increased promoter activity, MMP-3 tissue expression, and susceptibility to a number of vascular pathologies. The aim of this study was to determine whether the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
